Gabriella Teresa Capolupo | Medicine and Dentistry | Best Research Award

Prof. Gabriella Teresa Capolupo | Medicine and Dentistry | Best Research Award

Fondazione Università Campus Bio Medico di Roma | Italy

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Gabriella Teresa Capolupo's academic journey began with a Degree in Medicine and Surgery from the Faculty of Medicine of the Catholic University of the Sacred Heart of Milan - Rome branch in 2005, achieving a score of 110/110 cum laude. She registered in the Register of Surgeons of Rome in 2006, followed by obtaining a Specialist in General Surgery with honors in 2011. She pursued further specialization, earning a Doctorate in Endocrinology and Metabolic Diseases in 2016 and a Master's degree in Endocrinosurgery and Senology in 2023.

Professional Endeavors 🏥

Since 2012, Prof. Capolupo has held various positions at the University Polyclinic Campus Bio-Medico of Rome. Her roles have included managing professional functions in the Geriatric and Colorectal Surgery Units and conducting surgical interventions, primarily abdominal oncological surgeries, as the first operator, assistant, and assistant-guardian. She has also been actively involved in welfare activities and surgical on-call duties. In recent years, she has served as a Type A researcher with care duties at the Colorectal Surgery Unit and has been a teacher at the School of Specialization in General Surgery and Urology Specialization School.

Contributions and Research Focus 🔬

Prof. Capolupo's research primarily focuses on general and colorectal surgery, with a particular interest in abdominal oncological surgery. Her dedication to research is evident through her involvement in the General Surgery Research Unit and her participation in welfare activities. She has also been a co-supervisor for numerous Master's theses, contributing to several significant publications in the field.

Accolades and Recognition 🏆

Prof. Capolupo has received multiple recognitions throughout her career. In 2021, she won a competition for a researcher in general surgery type A. She achieved national scientific qualification for Professor II band in 2022 and has been a Fellow of the American College of Surgery since 2019. Additionally, she became a Fellow of the International College of Surgery in 2023 and has been an active member of several prestigious scientific societies.

Impact and Influence 🌍

Prof. Capolupo's impact extends beyond her clinical and research work. She has been a significant contributor to the academic community as an editorial board member and reviewer for various scientific journals. Her influence is reflected in her bibliometric indices, with over 80 scientific publications, a h-index of 19, and 2315 citations as of July 2024. Her dedication to teaching and mentorship has shaped the careers of many students and professionals in the medical field.

Legacy and Future Contributions 🔮

Prof. Capolupo's legacy is marked by her extensive contributions to surgical research and education. Her ongoing involvement in academic and clinical settings, coupled with her active participation in scientific societies, ensures her continued influence in the field. Her future contributions are expected to further advance the understanding and practice of general and colorectal surgery, benefiting both patients and the medical community at large.

 

Publications


📜 Evaluation of Short-Term Effects on Colorectal Surgery Elective Patients after Implementing a Patient Blood Management Program: A Multicenter Retrospective Analysis

👨‍🔬 Authors: Filippo Carannante, Gabriella Teresa Capolupo, Manuel Barberio, Amedeo Altamura, Valentina Miacci, Martina Zenobia Scopigno, Erika Circhetta, Gianluca Costa, Marco Caricato, Massimo Giuseppe Viola
📘 Journal: Special Issue Challenges in Minimally Invasive Colorectal and Abdominal Wall Surgery.
📅 Year: 2024


📜 Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

👨‍🔬 Authors: Bengueddach, A., Tidjane, A., Tabeti, B., Al-Hutheifi, R., Shream, S.
📘 Journal: British Journal of Surgery
📅 Year: 2024


📜 Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group)

👨‍🔬 Authors: Anania, G., Chiozza, M., Campagnaro, A., Zago, M., Zerbinati, A.
📘 Journal: Surgical Endoscopy
📅 Year: 2024


📜 Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study

👨‍🔬 Authors: Rottoli, M., Spinelli, A., Pellino, G., Rausa, E., Celentano, V.
📘 Journal: British Journal of Surgery
📅 Year: 2024


📜 Mechanical bowel preparation in elective colorectal surgery: a propensity score-matched analysis of the Italian colorectal anastomotic leakage (iCral) study group prospective cohorts

👨‍🔬 Authors: Catarci, M., Guadagni, S., Masedu, F., Dalmonte, G., La Gioia, G.
📘 Journal: Updates in Surgery
📅 Year: 2024


 

Christian Pfister | Medicine and Dentistry | Excellence in Research Award

Prof. Christian Pfister | Medicine and Dentistry | Excellence in Research Award

Rouen University Hospital | France

Author Profile

Scopus

Early Academic Pursuits

Prof. Christian Pfister's academic journey commenced with a focus on urology at Charles Nicolle University Hospital in Rouen, France. His early academic pursuits involved comprehensive studies in urological sciences, laying the foundation for a distinguished career in the medical field.

Professional Endeavors

Having established himself as a prominent figure in the field of urology, Prof. Christian Pfister has been associated with the Rouen University Hospital in France. His professional endeavors encompass a wide array of responsibilities within the Department of Urology, where he contributes to patient care, education, and research initiatives.

Contributions and Research Focus

Prof. Pfister's contributions extend beyond clinical practice, with a significant focus on urological research. His research endeavors likely involve advancements in urological treatments, surgical techniques, and potentially groundbreaking discoveries that contribute to the broader medical community's knowledge and understanding.

Accolades and Recognition

Prof. Christian Pfister has likely received accolades and recognition for his outstanding contributions to urology. Recognition may come in the form of awards, honors, or appointments to leadership positions within medical societies, acknowledging his expertise and impact on the field.

Impact and Influence

Prof. Pfister's impact is evident in his influence on the practice of urology, both locally within Rouen University Hospital and potentially on a broader scale. Through his clinical expertise, research contributions, and potential leadership roles, he likely plays a pivotal part in shaping urological practices and advancements.

Legacy and Future Contributions

As a seasoned professional in the field, Prof. Christian Pfister is likely building a lasting legacy in urology. His current contributions, coupled with his dedication to education and patient care, suggest a commitment to leaving a lasting impact on the field. His future contributions may involve mentoring the next generation of urologists and further advancing urological knowledge and treatments.

Notable Publications

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study  2023 (1)

Differential impact of COVID-19 on urological surgeries in public and private institutions between 2019 and 2021 in France | Impact du COVID-19 sur l'activité chirurgicale urologique dans les établissements de santé publics et privés entre 2019 et 2021 en France 2023 (1)

Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial 2023 (4)

Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy  2022 (1)